Global IVIG Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “IVIG Industry Forecast” looks at past sales and reviews total world IVIG sales in 2022, providing a comprehensive analysis by region and market sector of projected IVIG sales for 2023 through 2029. With IVIG sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVIG industry.
This Insight Report provides a comprehensive analysis of the global IVIG landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVIG portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IVIG market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVIG and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVIG.
The global IVIG market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IVIG players cover Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IVIG market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global IVIG market?
What factors are driving IVIG market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVIG market opportunities vary by end market size?
How does IVIG break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “IVIG Industry Forecast” looks at past sales and reviews total world IVIG sales in 2022, providing a comprehensive analysis by region and market sector of projected IVIG sales for 2023 through 2029. With IVIG sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVIG industry.
This Insight Report provides a comprehensive analysis of the global IVIG landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVIG portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IVIG market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVIG and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVIG.
The global IVIG market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IVIG is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IVIG players cover Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IVIG market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Injection IVIG
- Lyophilized Powder IVIG
- Multiple Sclerosis(MS)
- Myasthenia Gravis(MG)
- Multifocal Motor Neuropathy(MMN)
- Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
- Dermatomyositis
- Polymyositis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Green Cross
- BSV
- Hualan Bio
- RAAS
- YUAN DA SHUYANG
- Kangbao Bio
- Tiantan Bio
- Taibang Bio
- Weiguang Bio
- SIBP
- TONROL
- RUIDE Bio
- BOYA Bio
- RUIDE Bio
- Xinxing Medicine
- Weilun Bio
- WIBP
What is the 10-year outlook for the global IVIG market?
What factors are driving IVIG market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVIG market opportunities vary by end market size?
How does IVIG break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IVIG Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for IVIG by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for IVIG by Country/Region, 2018, 2022 & 2029
2.2 IVIG Segment by Type
2.2.1 Injection IVIG
2.2.2 Lyophilized Powder IVIG
2.3 IVIG Sales by Type
2.3.1 Global IVIG Sales Market Share by Type (2018-2023)
2.3.2 Global IVIG Revenue and Market Share by Type (2018-2023)
2.3.3 Global IVIG Sale Price by Type (2018-2023)
2.4 IVIG Segment by Application
2.4.1 Multiple Sclerosis(MS)
2.4.2 Myasthenia Gravis(MG)
2.4.3 Multifocal Motor Neuropathy(MMN)
2.4.4 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
2.4.5 Dermatomyositis
2.4.6 Polymyositis
2.5 IVIG Sales by Application
2.5.1 Global IVIG Sale Market Share by Application (2018-2023)
2.5.2 Global IVIG Revenue and Market Share by Application (2018-2023)
2.5.3 Global IVIG Sale Price by Application (2018-2023)
3 GLOBAL IVIG BY COMPANY
3.1 Global IVIG Breakdown Data by Company
3.1.1 Global IVIG Annual Sales by Company (2018-2023)
3.1.2 Global IVIG Sales Market Share by Company (2018-2023)
3.2 Global IVIG Annual Revenue by Company (2018-2023)
3.2.1 Global IVIG Revenue by Company (2018-2023)
3.2.2 Global IVIG Revenue Market Share by Company (2018-2023)
3.3 Global IVIG Sale Price by Company
3.4 Key Manufacturers IVIG Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IVIG Product Location Distribution
3.4.2 Players IVIG Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IVIG BY GEOGRAPHIC REGION
4.1 World Historic IVIG Market Size by Geographic Region (2018-2023)
4.1.1 Global IVIG Annual Sales by Geographic Region (2018-2023)
4.1.2 Global IVIG Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic IVIG Market Size by Country/Region (2018-2023)
4.2.1 Global IVIG Annual Sales by Country/Region (2018-2023)
4.2.2 Global IVIG Annual Revenue by Country/Region (2018-2023)
4.3 Americas IVIG Sales Growth
4.4 APAC IVIG Sales Growth
4.5 Europe IVIG Sales Growth
4.6 Middle East & Africa IVIG Sales Growth
5 AMERICAS
5.1 Americas IVIG Sales by Country
5.1.1 Americas IVIG Sales by Country (2018-2023)
5.1.2 Americas IVIG Revenue by Country (2018-2023)
5.2 Americas IVIG Sales by Type
5.3 Americas IVIG Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVIG Sales by Region
6.1.1 APAC IVIG Sales by Region (2018-2023)
6.1.2 APAC IVIG Revenue by Region (2018-2023)
6.2 APAC IVIG Sales by Type
6.3 APAC IVIG Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country (2018-2023)
7.1.2 Europe IVIG Revenue by Country (2018-2023)
7.2 Europe IVIG Sales by Type
7.3 Europe IVIG Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IVIG by Country
8.1.1 Middle East & Africa IVIG Sales by Country (2018-2023)
8.1.2 Middle East & Africa IVIG Revenue by Country (2018-2023)
8.2 Middle East & Africa IVIG Sales by Type
8.3 Middle East & Africa IVIG Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IVIG
10.3 Manufacturing Process Analysis of IVIG
10.4 Industry Chain Structure of IVIG
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IVIG Distributors
11.3 IVIG Customer
12 WORLD FORECAST REVIEW FOR IVIG BY GEOGRAPHIC REGION
12.1 Global IVIG Market Size Forecast by Region
12.1.1 Global IVIG Forecast by Region (2024-2029)
12.1.2 Global IVIG Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IVIG Forecast by Type
12.7 Global IVIG Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Green Cross
13.1.1 Green Cross Company Information
13.1.2 Green Cross IVIG Product Portfolios and Specifications
13.1.3 Green Cross IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Green Cross Main Business Overview
13.1.5 Green Cross Latest Developments
13.2 BSV
13.2.1 BSV Company Information
13.2.2 BSV IVIG Product Portfolios and Specifications
13.2.3 BSV IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BSV Main Business Overview
13.2.5 BSV Latest Developments
13.3 Hualan Bio
13.3.1 Hualan Bio Company Information
13.3.2 Hualan Bio IVIG Product Portfolios and Specifications
13.3.3 Hualan Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hualan Bio Main Business Overview
13.3.5 Hualan Bio Latest Developments
13.4 RAAS
13.4.1 RAAS Company Information
13.4.2 RAAS IVIG Product Portfolios and Specifications
13.4.3 RAAS IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 RAAS Main Business Overview
13.4.5 RAAS Latest Developments
13.5 YUAN DA SHUYANG
13.5.1 YUAN DA SHUYANG Company Information
13.5.2 YUAN DA SHUYANG IVIG Product Portfolios and Specifications
13.5.3 YUAN DA SHUYANG IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 YUAN DA SHUYANG Main Business Overview
13.5.5 YUAN DA SHUYANG Latest Developments
13.6 Kangbao Bio
13.6.1 Kangbao Bio Company Information
13.6.2 Kangbao Bio IVIG Product Portfolios and Specifications
13.6.3 Kangbao Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kangbao Bio Main Business Overview
13.6.5 Kangbao Bio Latest Developments
13.7 Tiantan Bio
13.7.1 Tiantan Bio Company Information
13.7.2 Tiantan Bio IVIG Product Portfolios and Specifications
13.7.3 Tiantan Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tiantan Bio Main Business Overview
13.7.5 Tiantan Bio Latest Developments
13.8 Taibang Bio
13.8.1 Taibang Bio Company Information
13.8.2 Taibang Bio IVIG Product Portfolios and Specifications
13.8.3 Taibang Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Taibang Bio Main Business Overview
13.8.5 Taibang Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio IVIG Product Portfolios and Specifications
13.9.3 Weiguang Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 SIBP
13.10.1 SIBP Company Information
13.10.2 SIBP IVIG Product Portfolios and Specifications
13.10.3 SIBP IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SIBP Main Business Overview
13.10.5 SIBP Latest Developments
13.11 TONROL
13.11.1 TONROL Company Information
13.11.2 TONROL IVIG Product Portfolios and Specifications
13.11.3 TONROL IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 TONROL Main Business Overview
13.11.5 TONROL Latest Developments
13.12 RUIDE Bio
13.12.1 RUIDE Bio Company Information
13.12.2 RUIDE Bio IVIG Product Portfolios and Specifications
13.12.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 RUIDE Bio Main Business Overview
13.12.5 RUIDE Bio Latest Developments
13.13 BOYA Bio
13.13.1 BOYA Bio Company Information
13.13.2 BOYA Bio IVIG Product Portfolios and Specifications
13.13.3 BOYA Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 BOYA Bio Main Business Overview
13.13.5 BOYA Bio Latest Developments
13.14 RUIDE Bio
13.14.1 RUIDE Bio Company Information
13.14.2 RUIDE Bio IVIG Product Portfolios and Specifications
13.14.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 RUIDE Bio Main Business Overview
13.14.5 RUIDE Bio Latest Developments
13.15 Xinxing Medicine
13.15.1 Xinxing Medicine Company Information
13.15.2 Xinxing Medicine IVIG Product Portfolios and Specifications
13.15.3 Xinxing Medicine IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Xinxing Medicine Main Business Overview
13.15.5 Xinxing Medicine Latest Developments
13.16 Weilun Bio
13.16.1 Weilun Bio Company Information
13.16.2 Weilun Bio IVIG Product Portfolios and Specifications
13.16.3 Weilun Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Weilun Bio Main Business Overview
13.16.5 Weilun Bio Latest Developments
13.17 WIBP
13.17.1 WIBP Company Information
13.17.2 WIBP IVIG Product Portfolios and Specifications
13.17.3 WIBP IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 WIBP Main Business Overview
13.17.5 WIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IVIG Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for IVIG by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for IVIG by Country/Region, 2018, 2022 & 2029
2.2 IVIG Segment by Type
2.2.1 Injection IVIG
2.2.2 Lyophilized Powder IVIG
2.3 IVIG Sales by Type
2.3.1 Global IVIG Sales Market Share by Type (2018-2023)
2.3.2 Global IVIG Revenue and Market Share by Type (2018-2023)
2.3.3 Global IVIG Sale Price by Type (2018-2023)
2.4 IVIG Segment by Application
2.4.1 Multiple Sclerosis(MS)
2.4.2 Myasthenia Gravis(MG)
2.4.3 Multifocal Motor Neuropathy(MMN)
2.4.4 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
2.4.5 Dermatomyositis
2.4.6 Polymyositis
2.5 IVIG Sales by Application
2.5.1 Global IVIG Sale Market Share by Application (2018-2023)
2.5.2 Global IVIG Revenue and Market Share by Application (2018-2023)
2.5.3 Global IVIG Sale Price by Application (2018-2023)
3 GLOBAL IVIG BY COMPANY
3.1 Global IVIG Breakdown Data by Company
3.1.1 Global IVIG Annual Sales by Company (2018-2023)
3.1.2 Global IVIG Sales Market Share by Company (2018-2023)
3.2 Global IVIG Annual Revenue by Company (2018-2023)
3.2.1 Global IVIG Revenue by Company (2018-2023)
3.2.2 Global IVIG Revenue Market Share by Company (2018-2023)
3.3 Global IVIG Sale Price by Company
3.4 Key Manufacturers IVIG Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IVIG Product Location Distribution
3.4.2 Players IVIG Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IVIG BY GEOGRAPHIC REGION
4.1 World Historic IVIG Market Size by Geographic Region (2018-2023)
4.1.1 Global IVIG Annual Sales by Geographic Region (2018-2023)
4.1.2 Global IVIG Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic IVIG Market Size by Country/Region (2018-2023)
4.2.1 Global IVIG Annual Sales by Country/Region (2018-2023)
4.2.2 Global IVIG Annual Revenue by Country/Region (2018-2023)
4.3 Americas IVIG Sales Growth
4.4 APAC IVIG Sales Growth
4.5 Europe IVIG Sales Growth
4.6 Middle East & Africa IVIG Sales Growth
5 AMERICAS
5.1 Americas IVIG Sales by Country
5.1.1 Americas IVIG Sales by Country (2018-2023)
5.1.2 Americas IVIG Revenue by Country (2018-2023)
5.2 Americas IVIG Sales by Type
5.3 Americas IVIG Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVIG Sales by Region
6.1.1 APAC IVIG Sales by Region (2018-2023)
6.1.2 APAC IVIG Revenue by Region (2018-2023)
6.2 APAC IVIG Sales by Type
6.3 APAC IVIG Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country (2018-2023)
7.1.2 Europe IVIG Revenue by Country (2018-2023)
7.2 Europe IVIG Sales by Type
7.3 Europe IVIG Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IVIG by Country
8.1.1 Middle East & Africa IVIG Sales by Country (2018-2023)
8.1.2 Middle East & Africa IVIG Revenue by Country (2018-2023)
8.2 Middle East & Africa IVIG Sales by Type
8.3 Middle East & Africa IVIG Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IVIG
10.3 Manufacturing Process Analysis of IVIG
10.4 Industry Chain Structure of IVIG
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IVIG Distributors
11.3 IVIG Customer
12 WORLD FORECAST REVIEW FOR IVIG BY GEOGRAPHIC REGION
12.1 Global IVIG Market Size Forecast by Region
12.1.1 Global IVIG Forecast by Region (2024-2029)
12.1.2 Global IVIG Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IVIG Forecast by Type
12.7 Global IVIG Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Green Cross
13.1.1 Green Cross Company Information
13.1.2 Green Cross IVIG Product Portfolios and Specifications
13.1.3 Green Cross IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Green Cross Main Business Overview
13.1.5 Green Cross Latest Developments
13.2 BSV
13.2.1 BSV Company Information
13.2.2 BSV IVIG Product Portfolios and Specifications
13.2.3 BSV IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BSV Main Business Overview
13.2.5 BSV Latest Developments
13.3 Hualan Bio
13.3.1 Hualan Bio Company Information
13.3.2 Hualan Bio IVIG Product Portfolios and Specifications
13.3.3 Hualan Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hualan Bio Main Business Overview
13.3.5 Hualan Bio Latest Developments
13.4 RAAS
13.4.1 RAAS Company Information
13.4.2 RAAS IVIG Product Portfolios and Specifications
13.4.3 RAAS IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 RAAS Main Business Overview
13.4.5 RAAS Latest Developments
13.5 YUAN DA SHUYANG
13.5.1 YUAN DA SHUYANG Company Information
13.5.2 YUAN DA SHUYANG IVIG Product Portfolios and Specifications
13.5.3 YUAN DA SHUYANG IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 YUAN DA SHUYANG Main Business Overview
13.5.5 YUAN DA SHUYANG Latest Developments
13.6 Kangbao Bio
13.6.1 Kangbao Bio Company Information
13.6.2 Kangbao Bio IVIG Product Portfolios and Specifications
13.6.3 Kangbao Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kangbao Bio Main Business Overview
13.6.5 Kangbao Bio Latest Developments
13.7 Tiantan Bio
13.7.1 Tiantan Bio Company Information
13.7.2 Tiantan Bio IVIG Product Portfolios and Specifications
13.7.3 Tiantan Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tiantan Bio Main Business Overview
13.7.5 Tiantan Bio Latest Developments
13.8 Taibang Bio
13.8.1 Taibang Bio Company Information
13.8.2 Taibang Bio IVIG Product Portfolios and Specifications
13.8.3 Taibang Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Taibang Bio Main Business Overview
13.8.5 Taibang Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio IVIG Product Portfolios and Specifications
13.9.3 Weiguang Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 SIBP
13.10.1 SIBP Company Information
13.10.2 SIBP IVIG Product Portfolios and Specifications
13.10.3 SIBP IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SIBP Main Business Overview
13.10.5 SIBP Latest Developments
13.11 TONROL
13.11.1 TONROL Company Information
13.11.2 TONROL IVIG Product Portfolios and Specifications
13.11.3 TONROL IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 TONROL Main Business Overview
13.11.5 TONROL Latest Developments
13.12 RUIDE Bio
13.12.1 RUIDE Bio Company Information
13.12.2 RUIDE Bio IVIG Product Portfolios and Specifications
13.12.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 RUIDE Bio Main Business Overview
13.12.5 RUIDE Bio Latest Developments
13.13 BOYA Bio
13.13.1 BOYA Bio Company Information
13.13.2 BOYA Bio IVIG Product Portfolios and Specifications
13.13.3 BOYA Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 BOYA Bio Main Business Overview
13.13.5 BOYA Bio Latest Developments
13.14 RUIDE Bio
13.14.1 RUIDE Bio Company Information
13.14.2 RUIDE Bio IVIG Product Portfolios and Specifications
13.14.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 RUIDE Bio Main Business Overview
13.14.5 RUIDE Bio Latest Developments
13.15 Xinxing Medicine
13.15.1 Xinxing Medicine Company Information
13.15.2 Xinxing Medicine IVIG Product Portfolios and Specifications
13.15.3 Xinxing Medicine IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Xinxing Medicine Main Business Overview
13.15.5 Xinxing Medicine Latest Developments
13.16 Weilun Bio
13.16.1 Weilun Bio Company Information
13.16.2 Weilun Bio IVIG Product Portfolios and Specifications
13.16.3 Weilun Bio IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Weilun Bio Main Business Overview
13.16.5 Weilun Bio Latest Developments
13.17 WIBP
13.17.1 WIBP Company Information
13.17.2 WIBP IVIG Product Portfolios and Specifications
13.17.3 WIBP IVIG Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 WIBP Main Business Overview
13.17.5 WIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IVIG Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. IVIG Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection IVIG
Table 4. Major Players of Lyophilized Powder IVIG
Table 5. Global IVIG Sales by Type (2018-2023) & (K Pcs)
Table 6. Global IVIG Sales Market Share by Type (2018-2023)
Table 7. Global IVIG Revenue by Type (2018-2023) & ($ million)
Table 8. Global IVIG Revenue Market Share by Type (2018-2023)
Table 9. Global IVIG Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global IVIG Sales by Application (2018-2023) & (K Pcs)
Table 11. Global IVIG Sales Market Share by Application (2018-2023)
Table 12. Global IVIG Revenue by Application (2018-2023)
Table 13. Global IVIG Revenue Market Share by Application (2018-2023)
Table 14. Global IVIG Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global IVIG Sales by Company (2018-2023) & (K Pcs)
Table 16. Global IVIG Sales Market Share by Company (2018-2023)
Table 17. Global IVIG Revenue by Company (2018-2023) ($ Millions)
Table 18. Global IVIG Revenue Market Share by Company (2018-2023)
Table 19. Global IVIG Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers IVIG Producing Area Distribution and Sales Area
Table 21. Players IVIG Products Offered
Table 22. IVIG Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global IVIG Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global IVIG Sales Market Share Geographic Region (2018-2023)
Table 27. Global IVIG Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global IVIG Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global IVIG Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global IVIG Sales Market Share by Country/Region (2018-2023)
Table 31. Global IVIG Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global IVIG Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas IVIG Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas IVIG Sales Market Share by Country (2018-2023)
Table 35. Americas IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas IVIG Revenue Market Share by Country (2018-2023)
Table 37. Americas IVIG Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas IVIG Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC IVIG Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC IVIG Sales Market Share by Region (2018-2023)
Table 41. APAC IVIG Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC IVIG Revenue Market Share by Region (2018-2023)
Table 43. APAC IVIG Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC IVIG Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe IVIG Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe IVIG Sales Market Share by Country (2018-2023)
Table 47. Europe IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe IVIG Revenue Market Share by Country (2018-2023)
Table 49. Europe IVIG Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe IVIG Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa IVIG Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa IVIG Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa IVIG Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa IVIG Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa IVIG Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of IVIG
Table 58. Key Market Challenges & Risks of IVIG
Table 59. Key Industry Trends of IVIG
Table 60. IVIG Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. IVIG Distributors List
Table 63. IVIG Customer List
Table 64. Global IVIG Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global IVIG Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC IVIG Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC IVIG Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global IVIG Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global IVIG Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global IVIG Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global IVIG Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Green Cross Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 79. Green Cross IVIG Product Portfolios and Specifications
Table 80. Green Cross IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Green Cross Main Business
Table 82. Green Cross Latest Developments
Table 83. BSV Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 84. BSV IVIG Product Portfolios and Specifications
Table 85. BSV IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. BSV Main Business
Table 87. BSV Latest Developments
Table 88. Hualan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 89. Hualan Bio IVIG Product Portfolios and Specifications
Table 90. Hualan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. Hualan Bio Main Business
Table 92. Hualan Bio Latest Developments
Table 93. RAAS Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 94. RAAS IVIG Product Portfolios and Specifications
Table 95. RAAS IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 96. RAAS Main Business
Table 97. RAAS Latest Developments
Table 98. YUAN DA SHUYANG Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 99. YUAN DA SHUYANG IVIG Product Portfolios and Specifications
Table 100. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 101. YUAN DA SHUYANG Main Business
Table 102. YUAN DA SHUYANG Latest Developments
Table 103. Kangbao Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 104. Kangbao Bio IVIG Product Portfolios and Specifications
Table 105. Kangbao Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 106. Kangbao Bio Main Business
Table 107. Kangbao Bio Latest Developments
Table 108. Tiantan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 109. Tiantan Bio IVIG Product Portfolios and Specifications
Table 110. Tiantan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 111. Tiantan Bio Main Business
Table 112. Tiantan Bio Latest Developments
Table 113. Taibang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 114. Taibang Bio IVIG Product Portfolios and Specifications
Table 115. Taibang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 116. Taibang Bio Main Business
Table 117. Taibang Bio Latest Developments
Table 118. Weiguang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 119. Weiguang Bio IVIG Product Portfolios and Specifications
Table 120. Weiguang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 121. Weiguang Bio Main Business
Table 122. Weiguang Bio Latest Developments
Table 123. SIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 124. SIBP IVIG Product Portfolios and Specifications
Table 125. SIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 126. SIBP Main Business
Table 127. SIBP Latest Developments
Table 128. TONROL Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 129. TONROL IVIG Product Portfolios and Specifications
Table 130. TONROL IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 131. TONROL Main Business
Table 132. TONROL Latest Developments
Table 133. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 134. RUIDE Bio IVIG Product Portfolios and Specifications
Table 135. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 136. RUIDE Bio Main Business
Table 137. RUIDE Bio Latest Developments
Table 138. BOYA Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 139. BOYA Bio IVIG Product Portfolios and Specifications
Table 140. BOYA Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 141. BOYA Bio Main Business
Table 142. BOYA Bio Latest Developments
Table 143. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 144. RUIDE Bio IVIG Product Portfolios and Specifications
Table 145. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 146. RUIDE Bio Main Business
Table 147. RUIDE Bio Latest Developments
Table 148. Xinxing Medicine Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 149. Xinxing Medicine IVIG Product Portfolios and Specifications
Table 150. Xinxing Medicine IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 151. Xinxing Medicine Main Business
Table 152. Xinxing Medicine Latest Developments
Table 153. Weilun Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 154. Weilun Bio IVIG Product Portfolios and Specifications
Table 155. Weilun Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 156. Weilun Bio Main Business
Table 157. Weilun Bio Latest Developments
Table 158. WIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 159. WIBP IVIG Product Portfolios and Specifications
Table 160. WIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 161. WIBP Main Business
Table 162. WIBP Latest Developments
Table 1. IVIG Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. IVIG Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection IVIG
Table 4. Major Players of Lyophilized Powder IVIG
Table 5. Global IVIG Sales by Type (2018-2023) & (K Pcs)
Table 6. Global IVIG Sales Market Share by Type (2018-2023)
Table 7. Global IVIG Revenue by Type (2018-2023) & ($ million)
Table 8. Global IVIG Revenue Market Share by Type (2018-2023)
Table 9. Global IVIG Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global IVIG Sales by Application (2018-2023) & (K Pcs)
Table 11. Global IVIG Sales Market Share by Application (2018-2023)
Table 12. Global IVIG Revenue by Application (2018-2023)
Table 13. Global IVIG Revenue Market Share by Application (2018-2023)
Table 14. Global IVIG Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global IVIG Sales by Company (2018-2023) & (K Pcs)
Table 16. Global IVIG Sales Market Share by Company (2018-2023)
Table 17. Global IVIG Revenue by Company (2018-2023) ($ Millions)
Table 18. Global IVIG Revenue Market Share by Company (2018-2023)
Table 19. Global IVIG Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers IVIG Producing Area Distribution and Sales Area
Table 21. Players IVIG Products Offered
Table 22. IVIG Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global IVIG Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global IVIG Sales Market Share Geographic Region (2018-2023)
Table 27. Global IVIG Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global IVIG Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global IVIG Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global IVIG Sales Market Share by Country/Region (2018-2023)
Table 31. Global IVIG Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global IVIG Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas IVIG Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas IVIG Sales Market Share by Country (2018-2023)
Table 35. Americas IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas IVIG Revenue Market Share by Country (2018-2023)
Table 37. Americas IVIG Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas IVIG Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC IVIG Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC IVIG Sales Market Share by Region (2018-2023)
Table 41. APAC IVIG Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC IVIG Revenue Market Share by Region (2018-2023)
Table 43. APAC IVIG Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC IVIG Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe IVIG Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe IVIG Sales Market Share by Country (2018-2023)
Table 47. Europe IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe IVIG Revenue Market Share by Country (2018-2023)
Table 49. Europe IVIG Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe IVIG Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa IVIG Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa IVIG Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa IVIG Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa IVIG Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa IVIG Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa IVIG Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of IVIG
Table 58. Key Market Challenges & Risks of IVIG
Table 59. Key Industry Trends of IVIG
Table 60. IVIG Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. IVIG Distributors List
Table 63. IVIG Customer List
Table 64. Global IVIG Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global IVIG Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC IVIG Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC IVIG Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa IVIG Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa IVIG Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global IVIG Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global IVIG Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global IVIG Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global IVIG Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Green Cross Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 79. Green Cross IVIG Product Portfolios and Specifications
Table 80. Green Cross IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Green Cross Main Business
Table 82. Green Cross Latest Developments
Table 83. BSV Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 84. BSV IVIG Product Portfolios and Specifications
Table 85. BSV IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. BSV Main Business
Table 87. BSV Latest Developments
Table 88. Hualan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 89. Hualan Bio IVIG Product Portfolios and Specifications
Table 90. Hualan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. Hualan Bio Main Business
Table 92. Hualan Bio Latest Developments
Table 93. RAAS Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 94. RAAS IVIG Product Portfolios and Specifications
Table 95. RAAS IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 96. RAAS Main Business
Table 97. RAAS Latest Developments
Table 98. YUAN DA SHUYANG Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 99. YUAN DA SHUYANG IVIG Product Portfolios and Specifications
Table 100. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 101. YUAN DA SHUYANG Main Business
Table 102. YUAN DA SHUYANG Latest Developments
Table 103. Kangbao Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 104. Kangbao Bio IVIG Product Portfolios and Specifications
Table 105. Kangbao Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 106. Kangbao Bio Main Business
Table 107. Kangbao Bio Latest Developments
Table 108. Tiantan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 109. Tiantan Bio IVIG Product Portfolios and Specifications
Table 110. Tiantan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 111. Tiantan Bio Main Business
Table 112. Tiantan Bio Latest Developments
Table 113. Taibang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 114. Taibang Bio IVIG Product Portfolios and Specifications
Table 115. Taibang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 116. Taibang Bio Main Business
Table 117. Taibang Bio Latest Developments
Table 118. Weiguang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 119. Weiguang Bio IVIG Product Portfolios and Specifications
Table 120. Weiguang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 121. Weiguang Bio Main Business
Table 122. Weiguang Bio Latest Developments
Table 123. SIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 124. SIBP IVIG Product Portfolios and Specifications
Table 125. SIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 126. SIBP Main Business
Table 127. SIBP Latest Developments
Table 128. TONROL Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 129. TONROL IVIG Product Portfolios and Specifications
Table 130. TONROL IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 131. TONROL Main Business
Table 132. TONROL Latest Developments
Table 133. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 134. RUIDE Bio IVIG Product Portfolios and Specifications
Table 135. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 136. RUIDE Bio Main Business
Table 137. RUIDE Bio Latest Developments
Table 138. BOYA Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 139. BOYA Bio IVIG Product Portfolios and Specifications
Table 140. BOYA Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 141. BOYA Bio Main Business
Table 142. BOYA Bio Latest Developments
Table 143. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 144. RUIDE Bio IVIG Product Portfolios and Specifications
Table 145. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 146. RUIDE Bio Main Business
Table 147. RUIDE Bio Latest Developments
Table 148. Xinxing Medicine Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 149. Xinxing Medicine IVIG Product Portfolios and Specifications
Table 150. Xinxing Medicine IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 151. Xinxing Medicine Main Business
Table 152. Xinxing Medicine Latest Developments
Table 153. Weilun Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 154. Weilun Bio IVIG Product Portfolios and Specifications
Table 155. Weilun Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 156. Weilun Bio Main Business
Table 157. Weilun Bio Latest Developments
Table 158. WIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 159. WIBP IVIG Product Portfolios and Specifications
Table 160. WIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 161. WIBP Main Business
Table 162. WIBP Latest Developments
LIST OF FIGURES
Figure 1. Picture of IVIG
Figure 2. IVIG Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IVIG Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global IVIG Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. IVIG Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection IVIG
Figure 10. Product Picture of Lyophilized Powder IVIG
Figure 11. Global IVIG Sales Market Share by Type in 2022
Figure 12. Global IVIG Revenue Market Share by Type (2018-2023)
Figure 13. IVIG Consumed in Multiple Sclerosis(MS)
Figure 14. Global IVIG Market: Multiple Sclerosis(MS) (2018-2023) & (K Pcs)
Figure 15. IVIG Consumed in Myasthenia Gravis(MG)
Figure 16. Global IVIG Market: Myasthenia Gravis(MG) (2018-2023) & (K Pcs)
Figure 17. IVIG Consumed in Multifocal Motor Neuropathy(MMN)
Figure 18. Global IVIG Market: Multifocal Motor Neuropathy(MMN) (2018-2023) & (K Pcs)
Figure 19. IVIG Consumed in Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 20. Global IVIG Market: Multifocal Acquired Sensory and Motor Neuropathy(MADSAM) (2018-2023) & (K Pcs)
Figure 21. IVIG Consumed in Dermatomyositis
Figure 22. Global IVIG Market: Dermatomyositis (2018-2023) & (K Pcs)
Figure 23. IVIG Consumed in Polymyositis
Figure 24. Global IVIG Market: Polymyositis (2018-2023) & (K Pcs)
Figure 25. Global IVIG Sales Market Share by Application (2022)
Figure 26. Global IVIG Revenue Market Share by Application in 2022
Figure 27. IVIG Sales Market by Company in 2022 (K Pcs)
Figure 28. Global IVIG Sales Market Share by Company in 2022
Figure 29. IVIG Revenue Market by Company in 2022 ($ Million)
Figure 30. Global IVIG Revenue Market Share by Company in 2022
Figure 31. Global IVIG Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global IVIG Revenue Market Share by Geographic Region in 2022
Figure 33. Americas IVIG Sales 2018-2023 (K Pcs)
Figure 34. Americas IVIG Revenue 2018-2023 ($ Millions)
Figure 35. APAC IVIG Sales 2018-2023 (K Pcs)
Figure 36. APAC IVIG Revenue 2018-2023 ($ Millions)
Figure 37. Europe IVIG Sales 2018-2023 (K Pcs)
Figure 38. Europe IVIG Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa IVIG Sales 2018-2023 (K Pcs)
Figure 40. Middle East & Africa IVIG Revenue 2018-2023 ($ Millions)
Figure 41. Americas IVIG Sales Market Share by Country in 2022
Figure 42. Americas IVIG Revenue Market Share by Country in 2022
Figure 43. Americas IVIG Sales Market Share by Type (2018-2023)
Figure 44. Americas IVIG Sales Market Share by Application (2018-2023)
Figure 45. United States IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC IVIG Sales Market Share by Region in 2022
Figure 50. APAC IVIG Revenue Market Share by Regions in 2022
Figure 51. APAC IVIG Sales Market Share by Type (2018-2023)
Figure 52. APAC IVIG Sales Market Share by Application (2018-2023)
Figure 53. China IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 57. India IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe IVIG Sales Market Share by Country in 2022
Figure 61. Europe IVIG Revenue Market Share by Country in 2022
Figure 62. Europe IVIG Sales Market Share by Type (2018-2023)
Figure 63. Europe IVIG Sales Market Share by Application (2018-2023)
Figure 64. Germany IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 65. France IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa IVIG Sales Market Share by Country in 2022
Figure 70. Middle East & Africa IVIG Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa IVIG Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa IVIG Sales Market Share by Application (2018-2023)
Figure 73. Egypt IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of IVIG in 2022
Figure 79. Manufacturing Process Analysis of IVIG
Figure 80. Industry Chain Structure of IVIG
Figure 81. Channels of Distribution
Figure 82. Global IVIG Sales Market Forecast by Region (2024-2029)
Figure 83. Global IVIG Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global IVIG Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global IVIG Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global IVIG Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global IVIG Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of IVIG
Figure 2. IVIG Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IVIG Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global IVIG Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. IVIG Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection IVIG
Figure 10. Product Picture of Lyophilized Powder IVIG
Figure 11. Global IVIG Sales Market Share by Type in 2022
Figure 12. Global IVIG Revenue Market Share by Type (2018-2023)
Figure 13. IVIG Consumed in Multiple Sclerosis(MS)
Figure 14. Global IVIG Market: Multiple Sclerosis(MS) (2018-2023) & (K Pcs)
Figure 15. IVIG Consumed in Myasthenia Gravis(MG)
Figure 16. Global IVIG Market: Myasthenia Gravis(MG) (2018-2023) & (K Pcs)
Figure 17. IVIG Consumed in Multifocal Motor Neuropathy(MMN)
Figure 18. Global IVIG Market: Multifocal Motor Neuropathy(MMN) (2018-2023) & (K Pcs)
Figure 19. IVIG Consumed in Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 20. Global IVIG Market: Multifocal Acquired Sensory and Motor Neuropathy(MADSAM) (2018-2023) & (K Pcs)
Figure 21. IVIG Consumed in Dermatomyositis
Figure 22. Global IVIG Market: Dermatomyositis (2018-2023) & (K Pcs)
Figure 23. IVIG Consumed in Polymyositis
Figure 24. Global IVIG Market: Polymyositis (2018-2023) & (K Pcs)
Figure 25. Global IVIG Sales Market Share by Application (2022)
Figure 26. Global IVIG Revenue Market Share by Application in 2022
Figure 27. IVIG Sales Market by Company in 2022 (K Pcs)
Figure 28. Global IVIG Sales Market Share by Company in 2022
Figure 29. IVIG Revenue Market by Company in 2022 ($ Million)
Figure 30. Global IVIG Revenue Market Share by Company in 2022
Figure 31. Global IVIG Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global IVIG Revenue Market Share by Geographic Region in 2022
Figure 33. Americas IVIG Sales 2018-2023 (K Pcs)
Figure 34. Americas IVIG Revenue 2018-2023 ($ Millions)
Figure 35. APAC IVIG Sales 2018-2023 (K Pcs)
Figure 36. APAC IVIG Revenue 2018-2023 ($ Millions)
Figure 37. Europe IVIG Sales 2018-2023 (K Pcs)
Figure 38. Europe IVIG Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa IVIG Sales 2018-2023 (K Pcs)
Figure 40. Middle East & Africa IVIG Revenue 2018-2023 ($ Millions)
Figure 41. Americas IVIG Sales Market Share by Country in 2022
Figure 42. Americas IVIG Revenue Market Share by Country in 2022
Figure 43. Americas IVIG Sales Market Share by Type (2018-2023)
Figure 44. Americas IVIG Sales Market Share by Application (2018-2023)
Figure 45. United States IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC IVIG Sales Market Share by Region in 2022
Figure 50. APAC IVIG Revenue Market Share by Regions in 2022
Figure 51. APAC IVIG Sales Market Share by Type (2018-2023)
Figure 52. APAC IVIG Sales Market Share by Application (2018-2023)
Figure 53. China IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 57. India IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe IVIG Sales Market Share by Country in 2022
Figure 61. Europe IVIG Revenue Market Share by Country in 2022
Figure 62. Europe IVIG Sales Market Share by Type (2018-2023)
Figure 63. Europe IVIG Sales Market Share by Application (2018-2023)
Figure 64. Germany IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 65. France IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa IVIG Sales Market Share by Country in 2022
Figure 70. Middle East & Africa IVIG Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa IVIG Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa IVIG Sales Market Share by Application (2018-2023)
Figure 73. Egypt IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country IVIG Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of IVIG in 2022
Figure 79. Manufacturing Process Analysis of IVIG
Figure 80. Industry Chain Structure of IVIG
Figure 81. Channels of Distribution
Figure 82. Global IVIG Sales Market Forecast by Region (2024-2029)
Figure 83. Global IVIG Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global IVIG Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global IVIG Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global IVIG Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global IVIG Revenue Market Share Forecast by Application (2024-2029)
